To test this, we extracted gene expression levels for 65 proteins that were proximal to PARP1 and present at stressed replication forks, from breast, ovarian, and prostate cancer samples with wild-type or mutated BRCA1 or BRCA2 from the cBioPortal (78). This evidence concerns the gene BRCA2 and prostate cancer.